Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What's your current opinion of the business trajectory?
Got it! The only pragmatic reason they could/would pay down $65,000 in debt is because of their increased "profitable growth" so far in December/January.
Many of you seem to have excellent "trading" skills, so you leave me in the proverbial dust! I believe (old guy) that if you have the fundamentals, it really happens! The achieved profit in the 4th quarter with only "good" growth is extraordinary. Ballas has just stated that "we're back on track"!
Therefore this 11 month year old press release is quite relevant!:
Ubiquitech Strong 2015 Sales Lead to New Expanded Distribution Opportunities
Mar 07, 2016
OTC Disclosure & News Service
-
Ubiquitech Strong 2015 Sales Lead to New Expanded Distribution Opportunities
DENVER, CO--(Marketwired - Mar 7, 2016) - Ubiquitech Software Corp. (www.ubiquitechsoftware.com) (OTC PINK: UBQU), through its operating subsidiary HempLifeToday.com, known for developing the purest and most potent CBD Hemp derived products available and developer of the proprietary CBD brand CannazALL, recently reported its fiscal year 2015 results. The company's revenue expanded to over $3,000,000, and Ubiquitech also transitioned to profitability year over year.
Ubiquitech expects continued improvement in both gross margins and profitability as its new affiliate program takes hold. In its first quarter of 2016, the company has taken measures to solidify its position as a leader in online sales of CBD oil products through its proprietary CBD brand CannazALL. Ubiquitech anticipates that investments made during the first quarter for the build of its affiliate program will propel the company toward its 2016 sales goal of $10,000,000. Ubiquitech anticipates significant margin improvement as it continues to generate increased revenues with a lower cost structure.
"This investment made during our first quarter is another integral step toward achieving our 2016 revenue and profitability goals," said Tim Zorn, CEO of HempLife Today. "Our vision is clear and our focus strong as we continue to execute our business plan."
YES! I believe the "addl" 10,000 customers for 2016 takes us to a total coming in to the year of 25,000. So my attempt is to be conservative, yet optimistic. Therefore if the avg # of customers for the year is the 35,000 you suggested, then the $10,000,000 is NOT unrealistic. $10,000,000 revenue @$155.00 per order =app. 65,000 orders! Therefore LESS than (2) orders per customer in 2017!
This was last year's outlook from them.
We're likely looking at 2x revenue growth ($7.0 mil+) this year. Seeing $1.7 mil. Revenue in 1Q would begin to confirm this. It would drive more than $300,000 in gross profit likely yielding the ability to further pay down debt!
1Q is 2/3 completed and Ballas has "touted" it. Might the $65,000 reduction of debt in January direct us to having had a tremendous December and January, hence likely a great quarter?
10,000 added over the "year"; great if we could add 10,000 during this 1Q 2017!
Has anyone on this board spoken with Jim Ballas directly?
We don't know the details of the note. My guess is that there is a schedule and interest (8-10%) might be able to be paid differently. Guessing in lieu of facts. Interesting how many shares were issued in December?
Hoping for the best.
We don't know the details of the note. My guess is that there is a schedule and interest (8-10%) might be able to be paid differently. Guessing in lieu of facts. Interesting how many shares were issued in December?
Hoping for the best.
What would like the next PR to address?
It would ease my concerns if the note in the financials did not state "sole discretion of the note holder". So far they have accepted some cash and I hope it continues. Addendum to the note that states that the company can choose cash in lieu of the share conversion would be helpful.
Sooner or later a public company with a thriving business looking to become fully reporting will need a controller or CFO. They insist on certain things and do them. They would be handling the name/symbol change as well as disclosures. There are scores of retired pros who won't cost a arm & leg, even will work 3 days a week.
I sense this skill set is lacking.
Appreciate your analysis & thanks. What is your estimate of the number of shares will be converted out of the $557,000 owed to Common Sense Holdings?
My question is not gamesmanship. Given what they have done, do you guess 50/50 (cash vs shares) or......
If we could only look at the operating business, it's wildly successful although 4Q 2016 vs 4Q 2015 wasn't favorable. Therefore let us know that the note holder will accept any combination of cash & shares, fix the da__name & symbol change in the next few days, provide us some direction on 1Q's revenue and we're on track,
No! I'm not a trader and I like this business. The CC was an opportunity that was disappointing.
Conference call is a good idea, however you gotta have real & substantive content. Ballas is a media personality, therefore I expected him to soar on the conference call!
Name/symbol change lack of apparent progress is most perplexing! We were gathering information for this newest name change on January 10th.
Great you're back. We don't know anything differently about the terms of the convertible note. It is HUGE!
Share count going from 95 mil shares to well over 700,000,000 shares within 2 years with just what we know! Glad you bought 1 mil shares.
Conference call in 65 minutes. I hope that someone on Ubiquitech's team is monitoring this site. So between our sent questions and this forum they know what's on our minds.
Common Sense, LLC probably doesn't want sub-penny shares! That's somewhat comforting. Haven't sold a share but agree that the debt must be renegotiated; also wonder who is/are the partners in the LLC?
Smokey I've been a direct participant in a successful legal action against a Florida domiciled company that it took years to collect even after we won (we went to trial). Every rule that I "thought" was sacred they broke. RULE 144 stock, their "posse" circumvented the time line with the help of local attorneys (you just need the right kind of letter to clear the cert). I've looked up Ballas also to see "where" he has worked (can't find info).
The information regarding the "debt" was hiding in plain site under the supplemental disclosure last year but I didn't focus on it.
So I think it's folks like "you" and some others might be able to influence this company so that it is a better public company and realize what we can also see is achievable.
We now know much more than we did before the earnings release. WE HAVE A DEBT challenge and it needs to be renegotiated. It looks like 2016 was a year for REORGANIZING, yet there was some revenue growth and the efficiency improved in the operation to allow for greater profit. The ratio of revenue to profit improved enormously; can you imagine what we can do with $10,000,000 in revenue (clearly in excess of $1,000,000 in profits might be attainable)!
So I am eager to hear a clear explanation about RETIRING a renegotiated debt and plans to really significantly increase the demand!
I'd like to see an advisory board with some representation from a couple of you so that we can feel "closer" to the company and provide direct input. We need to become fully reporting and include a controller or CFO soon.
Of course the name/symbol/cusip has to happen quickly. It's very exciting what this company can achieve but there is some cleaning-up that needs done.
I don't know. Too many companies for me to keep up with.
EndoLabs features (2) shatter products; same as I guess that were trial products for us. 4Q results are still to be discussed especially, year over year. Should be exciting tomorrow.
Very promising company who's products and distribution channel are ahead of the competition! Too bad we're a public company "now" because the DD with even modest financial review is cumbersome.
Endolabs is a cannabis brand name,
Do you believe that the outstanding debt for Common Sense, L L C can be converted on different terms than are reflected in the note? $557,814 @.$001 is extraordinary in my view?
$557,814 are still owed @ a conversion of $.001 to Common Sense LLC I guess. That's staggering to me for the future, 2017/2018.
THANK you Smokey! I need to use E Trade. You're so right!
Consider going to the OTC Markets, enter our symbol, go to our fillings for the publish date of 1/25/2017, specifically supplemental information. If you scroll to (10) notes payables and read you will be knowledgeable as to the monthly issuance of "NEW" shares. I am all but certain that it HAS NOT stopped!
Common Sense Holdings, LLC (I guess) has much more coming to it and have the choice of conversion @$.001 in whole or in part at their "sole discretion"! 90,600,000 shares were issued in 4Q alone!
At minimum the question is, what should we expect to happen in 2017?
I kept wondering who Mr. Ballas was speaking about when he said, "we voted"!
I believe this came from Blue Crush.
125,750,000 shares issued to convert the note. WOW! Is the note holder Blue Crush? Therefore the note holder now "owns" 68% of the company? Who are the 1,000,000 preferred shares issued to.......
OS doubled in one year; it's a negative surprise for me. I do agree that it's still better relative to many other cannabis companies. So we are trading at a $6.1 mil market cap.
You're out off the country most of the time, aren't you? What do you see now that you would do differently? I hope you get back in because you helped to influence the communications we're getting tomorrow? When we're fully reporting a large stake will garner a lot of leverage without owning it outright!
Time to make up for what we temporarily lost on the anticipated name/symbol change! Should be great synergy over the next 10 days or so on earnings and name/symbol change. In fact I hope they have a great marketing plan just around the name/symbol change.
TOTALLY agree! We don't know until we review earnings and get a sense of direction from that release and discussions on the conference call. I have a feeling of pure excitement coupled with "anxiety"! Tired of guessing.
We're likely categorizing ourselves as a Cannabis-Biotech company. Seems to be the thought behind our new name to "expand" our ability to capitalize on growth and emerging technologies!
The earnings release is the big deal for the world to know; the conference call may not be well attended beyond "us" folks. So let's build anticipation!!!
Earnings release should be 1st thing tomorrow AM, therefore I'd expect heightened activity out of the gate! So I was hoping for a PR that got everyone excited (even beyond this forum)!!!